This investigation identified the ImmuView® S. pneumoniae and
L. pneumophila Urinary Antigen Test as the most sensitive point-ofcare
test for patients presenting with pneumonia. Moreover, the
ImmuView® also has the benefit of providing both results in one
assay, making it easier to performand cheaper to identify the correct infectious
agent. This combined testing also fits very well with the national
recommendation in different countries for simultaneous testing for
these two agents.